Profile of Psoriasis Vulgaris in Waled General Hospital, Cirebon, Indonesia: A Retrospective Study (January 2020-December 2023)
DOI:
https://doi.org/10.35898/ghmj-81s1157Keywords:
Psoriasis Vulgaris, Skin diseases, Red plaques, Systemic antihistamines treatment, Topical corticosteroids treatmentAbstract
Background: Psoriasis is a chronic skin disease that significantly impacts the quality of life. In Indonesia, it affects 2.5% of the population, with increasing cases observed in major hospitals. This study aimed to profile psoriasis vulgaris at Waled General Hospital, Cirebon, from January 2020 to December 2023.
Aims: To understand the profile of psoriasis vulgaris in the Dermatology and Venereology Clinic of Waled General Hospital, Cirebon Regency, for the period January 2020 to December 2023.
Methods: This study employed a descriptive, cross-sectional design with a retrospective approach to analyze secondary data sourced from medical records of patients treated at Waled General Hospital. The inclusion criteria focused on individuals diagnosed with psoriasis vulgaris who received treatment or consultation between January 2020 and December 2023, provided their medical records were complete. Conversely, the exclusion criteria removed patients diagnosed with other forms of psoriasis, such as guttate psoriasis, as well as those with incomplete records. The final sample size consisted of 56 patients, ensuring a focused and manageable dataset for analysis. By applying these criteria, the study aimed to provide a clear and accurate understanding of psoriasis vulgaris cases, ensuring the findings were both scientifically robust and clinically relevant.
Results: From January 2020 to December 2023, psoriasis vulgaris was most prevalent among the age group of 15-49 years, with a mean age of 42.3 ± 14.7 years comprising 53.57% of the cases. The female sex predominated over the male sex, with 53.57% versus 46.42%. The major clinical presentation in all cases was red plaques, 100%. Hypertension was the most common comorbid condition, affecting 17.85% of the patients. The universal systemic antihistamine used was 100%, while the topical corticosteroid used was performed for 80.35% of the cases.
Conclusion: These findings put into perspective the need for early recognition of symptoms, standardized treatment, and integrated care for comorbidities such as hypertension in a regional hospital setting. This study thus provides important lessons that could be used to improve psoriasis management by proactively identifying specific strategies to address demographic and clinical characteristics of affected populations and ultimately improve patient outcomes and resource use.
Downloads
References
Armstrong, A. W., Lin, S. W., Chambers, C. J., Sockolov, M. E., & Chin, D. L. (2011). Psoriasis and hypertension severity: Results from a case-control study. PLoS ONE, 6(3). https://doi.org/10.1371/journal.pone.0018227
Armstrong, A. W., & Read, C. (2020, May 19). Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA - Journal of the American Medical Association. American Medical Association. https://doi.org/10.1001/jama.2020.4006
Brazzelli, V., Maffioli, P., Bolcato, V., Ciolfi, C., D’Angelo, A., Tinelli, C., & Derosa, G. (2021). Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.605691
Brożyna, A. A., Slominski, R. M., Nedoszytko, B., Zmijewski, M. A., & Slominski, A. T. (2022, August 1). Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms23158575
Cassalia, F., Lunardon, A., Frattin, G., Danese, A., Caroppo, F., & Fortina, A. B. (2025, January 1). How Hormonal Balance Changes Lives in Women with Psoriasis. Journal of Clinical Medicine. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/jcm14020582
Dodulík, J., Dodulíková, L., Plášek, J., Ramík, Z., Vrtal, J., & Václavík, J. (2025, April 1). Pharmacotherapy of arterial hypertension in patients with psoriasis. Journal of Hypertension. Lippincott Williams and Wilkins. https://doi.org/10.1097/HJH.0000000000003982
Elmets, C. A., Korman, N. J., Prater, E. F., Wong, E. B., Rupani, R. N., Kivelevitch, D., … Menter, A. (2021). Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Journal of the American Academy of Dermatology, 84(2), 432–470. https://doi.org/10.1016/j.jaad.2020.07.087
Gregoire, A. R. F., Deruyter, B. K., & Stratman, E. J. (2021). Psoriasis Flares following Systemic Glucocorticoid Exposure in Patients with a History of Psoriasis. JAMA Dermatology, 157(2), 198–201. https://doi.org/10.1001/jamadermatol.2020.4219
Guillet, C., Seeli, C., Nina, M., Maul, L. V., & Maul, J. T. (2022). The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis. International Journal of Women’s Dermatology, 8(2). https://doi.org/10.1097/JW9.0000000000000010
Queiro, R., Tejón, P., Alonso, S., & Coto, P. (2014). Age at disease onset: A key factor for understanding psoriatic disease. Rheumatology (United Kingdom). Oxford University Press. https://doi.org/10.1093/rheumatology/ket363
Weber, B., Merola, J. F., Husni, M. E., Di Carli, M., Berger, J. S., & Garshick, M. S. (2021, November 1). Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics. Current Atherosclerosis Reports. Springer. https://doi.org/10.1007/s11883-021-00963-y
Sitton, B., Walker, T., Mital, R., Varra, V., & Kaffenberger, J. (2024, September 1). Antistreptococcal treatment of psoriasis: a systematic review. Archives of Dermatological Research. Springer Nature. https://doi.org/10.1007/s00403-024-03051-8
Napolitano, M., Mastroeni, S., Fania, L., Pallotta, S., Fusari, R., Uras, C., … Abeni, D. (2020). Sex- and gender-associated clinical and psychosocial characteristics of patients with psoriasis. Clinical and Experimental Dermatology, 45(6), 705–711. https://doi.org/10.1111/ced.14218
Zhao, M., Luo, J., Xiao, B., Tang, H., Song, F., Ding, X., & Yang, G. (2020). Endoplasmic reticulum stress links psoriasis vulgaris with keratinocyte inflammation. Postepy Dermatologii i Alergologii, 37(1), 34–40. https://doi.org/10.5114/ada.2020.93382
Woźniak, E., Owczarczyk-Saczonek, A., & Placek, W. (2021). Psychological stress, mast cells, and psoriasis—is there any relationship? International Journal of Molecular Sciences, 22(24). https://doi.org/10.3390/ijms222413252
Zhang, J., Zhao, S., Xing, X., Shang, L., Cao, J., & He, Y. (2023). Effects of Neuropeptides on Dendritic Cells in the Pathogenesis of Psoriasis. Journal of Inflammation Research. Dove Medical Press Ltd. https://doi.org/10.2147/JIR.S397079
Global Psoriasis Atlas. Prevalence Data Indonesia [Internet]. 2017. Available from: https://www.globalpsoriasisatlas.org
Damiani G, Bragazzi NL, Karimkhani Aksut C, Wu D, Alicandro G, McGonagle D, et al. The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study. Front Med (Lausanne). 2021 Dec 16;8. https://doi.org/10.3389/fmed.2021.743180
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Fadhlan Adiguna Putra S.Ked., dr. Frista Martha Rahayu Sp.DVE, dr. Maya Wahdini, Sp.KK
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
GHMJ (Global Health Management Journal) conforms fully to The Budapest Open Access Initiative (BOAI) and DOAJ Open Access Definition. Authors, readers, and reviewers are free to Share ” copy and redistribute the material in any medium or format, and Adapt ” remix, transform, and build upon the material. Author(s) retain unrestricted copyrights and publishing rights of their work. The licensor cannot revoke these freedoms as long as you follow the license terms. Learn the details at the License policy.
How to Cite
